Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CXCR4 ELISA Kit (AC3346)
Cat.#: ASET-1935
Specifications
Description Human CXCR4 ELISA Kit allows for the in vitro quantitative determination of human CXCR4 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1926 Porcine Neurotrophin 3 ELISA Kit (AC3337) Quantitative inquiry ASET-1238 Human HCN4 ELISA Kit (AC2649) Quantitative inquiry ASET-2468 Mouse SIRP alpha ELISA Kit (AC3879) Quantitative inquiry ASET-1865 Rat Mu Opioid Receptor ELISA Kit (AC3276) Quantitative inquiry ASET-1931 Rat Aromatase ELISA Kit (AC3342) Quantitative inquiry ASET-1359 Mouse Creatine Kinase B Type ELISA Kit (AC2770) Quantitative inquiry ASET-1784 Mouse DLL1 ELISA Kit (AC3195) Quantitative inquiry ASET-2173 Human NENF ELISA Kit (AC3584) Quantitative inquiry ASET-2336 Rat Synaptophysin ELISA Kit (AC3747) Quantitative inquiry ASET-1995 Human NRG4 ELISA Kit (AC3406) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket